Medical Device Network on MSN1d
Medtronic announces two-year trial outcomes of Evolut TAVR
Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial’s two-year ...
MassDevice1d
Medtronic has positive TAVR results in small aortic annulus patients
Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...
Zacks Investment Research on MSN1d
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
Medtronic plc MDT recently unveiled two-year Small Annuli Randomized to Evolut or SAPIEN (“SMART”) Trial results at the Cardiovascular Research Technologies (“CRT”) 2025 conference in Washington, D.C.
BioWorld1d
Medtronic sees SMART TAVR results in small aortic annulus patients
Medtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or ...
Medtronic releases two-year results of SMART trial for TAVR
Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...
Morningstar2d
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
"The two-year results highlight the continued superior performance of the Evolut TAVR valve in these patients. While we would not yet expect to see a significant difference in the composite ...
PharmiWeb1d
SMART Trial two-year data continues to demonstrate…
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
Nasdaq2d
Medtronic : Data Confirms Superior Valve Performance Of Evolut TAVR System In Small Annulus Patients
The SMART two-year data demonstrated that Evolut TAVR continues to show significantly less BVD, which can be a predictor of adverse outcomes, compared to SAPIEN TAVR. Additional results ...
Experts publish consensus on alternative access for transaortic valve replacement
The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...
Medindia3d
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR system in small annulus patients
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...
Stockhouse2d
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR(TM) system in small annulus patients
"The two-year results highlight the continued superior performance of the Evolut TAVR valve in these patients. While we would not yet expect to see a significant difference in the composite clinical ...
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...